2024-04-012025-03-312025-03-31false13989710MKOZ LIMITED2025-12-12falseiso4217:GBPxbrli:pure139897102024-03-31139897102025-03-31139897102024-04-012025-03-31139897102023-03-31139897102024-03-31139897102023-04-012024-03-3113989710bus:SmallEntities2024-04-012025-03-3113989710bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113989710bus:FullAccounts2024-04-012025-03-3113989710bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113989710core:WithinOneYear2025-03-3113989710core:AfterOneYear2025-03-3113989710core:WithinOneYear2024-03-3113989710core:AfterOneYear2024-03-3113989710core:ShareCapital2025-03-3113989710core:SharePremium2025-03-3113989710core:RevaluationReserve2025-03-3113989710core:OtherReservesSubtotal2025-03-3113989710core:RetainedEarningsAccumulatedLosses2025-03-3113989710core:ShareCapital2024-03-3113989710core:SharePremium2024-03-3113989710core:RevaluationReserve2024-03-3113989710core:OtherReservesSubtotal2024-03-3113989710core:RetainedEarningsAccumulatedLosses2024-03-3113989710core:LandBuildings2025-03-3113989710core:PlantMachinery2025-03-3113989710core:Vehicles2025-03-3113989710core:FurnitureFittings2025-03-3113989710core:OfficeEquipment2025-03-3113989710core:NetGoodwill2025-03-3113989710core:IntangibleAssetsOtherThanGoodwill2025-03-3113989710core:ListedExchangeTraded2025-03-3113989710core:UnlistedNon-exchangeTraded2025-03-3113989710core:LandBuildings2024-03-3113989710core:PlantMachinery2024-03-3113989710core:Vehicles2024-03-3113989710core:FurnitureFittings2024-03-3113989710core:OfficeEquipment2024-03-3113989710core:NetGoodwill2024-03-3113989710core:IntangibleAssetsOtherThanGoodwill2024-03-3113989710core:ListedExchangeTraded2024-03-3113989710core:UnlistedNon-exchangeTraded2024-03-3113989710core:LandBuildings2024-04-012025-03-3113989710core:PlantMachinery2024-04-012025-03-3113989710core:Vehicles2024-04-012025-03-3113989710core:FurnitureFittings2024-04-012025-03-3113989710core:OfficeEquipment2024-04-012025-03-3113989710core:NetGoodwill2024-04-012025-03-3113989710core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113989710core:ListedExchangeTraded2024-04-012025-03-3113989710core:UnlistedNon-exchangeTraded2024-04-012025-03-3113989710core:MoreThanFiveYears2024-04-012025-03-3113989710core:Non-currentFinancialInstruments2025-03-3113989710core:Non-currentFinancialInstruments2024-03-3113989710dpl:CostSales2024-04-012025-03-3113989710dpl:DistributionCosts2024-04-012025-03-3113989710core:LandBuildings2024-04-012025-03-3113989710core:PlantMachinery2024-04-012025-03-3113989710core:Vehicles2024-04-012025-03-3113989710core:FurnitureFittings2024-04-012025-03-3113989710core:OfficeEquipment2024-04-012025-03-3113989710dpl:AdministrativeExpenses2024-04-012025-03-3113989710core:NetGoodwill2024-04-012025-03-3113989710core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113989710dpl:GroupUndertakings2024-04-012025-03-3113989710dpl:ParticipatingInterests2024-04-012025-03-3113989710dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113989710core:ListedExchangeTraded2024-04-012025-03-3113989710dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113989710core:UnlistedNon-exchangeTraded2024-04-012025-03-3113989710dpl:CostSales2023-04-012024-03-3113989710dpl:DistributionCosts2023-04-012024-03-3113989710core:LandBuildings2023-04-012024-03-3113989710core:PlantMachinery2023-04-012024-03-3113989710core:Vehicles2023-04-012024-03-3113989710core:FurnitureFittings2023-04-012024-03-3113989710core:OfficeEquipment2023-04-012024-03-3113989710dpl:AdministrativeExpenses2023-04-012024-03-3113989710core:NetGoodwill2023-04-012024-03-3113989710core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113989710dpl:GroupUndertakings2023-04-012024-03-3113989710dpl:ParticipatingInterests2023-04-012024-03-3113989710dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113989710core:ListedExchangeTraded2023-04-012024-03-3113989710dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113989710core:UnlistedNon-exchangeTraded2023-04-012024-03-3113989710core:NetGoodwill2025-03-3113989710core:IntangibleAssetsOtherThanGoodwill2025-03-3113989710core:LandBuildings2025-03-3113989710core:PlantMachinery2025-03-3113989710core:Vehicles2025-03-3113989710core:FurnitureFittings2025-03-3113989710core:OfficeEquipment2025-03-3113989710core:AfterOneYear2025-03-3113989710core:WithinOneYear2025-03-3113989710core:ListedExchangeTraded2025-03-3113989710core:UnlistedNon-exchangeTraded2025-03-3113989710core:ShareCapital2025-03-3113989710core:SharePremium2025-03-3113989710core:RevaluationReserve2025-03-3113989710core:OtherReservesSubtotal2025-03-3113989710core:RetainedEarningsAccumulatedLosses2025-03-3113989710core:NetGoodwill2024-03-3113989710core:IntangibleAssetsOtherThanGoodwill2024-03-3113989710core:LandBuildings2024-03-3113989710core:PlantMachinery2024-03-3113989710core:Vehicles2024-03-3113989710core:FurnitureFittings2024-03-3113989710core:OfficeEquipment2024-03-3113989710core:AfterOneYear2024-03-3113989710core:WithinOneYear2024-03-3113989710core:ListedExchangeTraded2024-03-3113989710core:UnlistedNon-exchangeTraded2024-03-3113989710core:ShareCapital2024-03-3113989710core:SharePremium2024-03-3113989710core:RevaluationReserve2024-03-3113989710core:OtherReservesSubtotal2024-03-3113989710core:RetainedEarningsAccumulatedLosses2024-03-3113989710core:NetGoodwill2023-03-3113989710core:IntangibleAssetsOtherThanGoodwill2023-03-3113989710core:LandBuildings2023-03-3113989710core:PlantMachinery2023-03-3113989710core:Vehicles2023-03-3113989710core:FurnitureFittings2023-03-3113989710core:OfficeEquipment2023-03-3113989710core:AfterOneYear2023-03-3113989710core:WithinOneYear2023-03-3113989710core:ListedExchangeTraded2023-03-3113989710core:UnlistedNon-exchangeTraded2023-03-3113989710core:ShareCapital2023-03-3113989710core:SharePremium2023-03-3113989710core:RevaluationReserve2023-03-3113989710core:OtherReservesSubtotal2023-03-3113989710core:RetainedEarningsAccumulatedLosses2023-03-3113989710core:AfterOneYear2024-04-012025-03-3113989710core:WithinOneYear2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113989710core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113989710core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113989710core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113989710core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113989710core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113989710bus:Director12024-04-012025-03-31139897101bus:Director12024-03-31139897101bus:Director12024-04-012025-03-31139897101bus:Director12025-03-31139897102024-03-31139897102024-04-012025-03-31139897102025-03-31

MKOZ LIMITED

Registered Number
13989710
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

MKOZ LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Dr Marta Kozlowska

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

13989710 (England and Wales)
MKOZ LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets32,9853,653
2,9853,653
Current assets
Debtors414,95610,722
Cash at bank and on hand19,22831,630
34,18442,352
Creditors amounts falling due within one year5(24,802)(24,778)
Net current assets (liabilities)9,38217,574
Total assets less current liabilities12,36721,227
Net assets12,36721,227
Capital and reserves
Called up share capital100100
Profit and loss account12,26721,127
Shareholders' funds12,36721,227
The financial statements were approved and authorised for issue by the Director on 12 December 2025, and are signed on its behalf by:
Dr Marta Kozlowska
Director
Registered Company No. 13989710
MKOZ LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Office Equipment20
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 243,3471,7485,095
Additions-7979
At 31 March 253,3471,8275,174
Depreciation and impairment
At 01 April 248126301,442
Charge for year747-747
At 31 March 251,5596302,189
Net book value
At 31 March 251,7881,1972,985
At 31 March 242,5351,1183,653
4.Debtors: amounts due after one year
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables20230
Taxation and social security24,32123,584
Other creditors-597
Accrued liabilities and deferred income461367
Total24,80224,778
6.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Dr Marta Kozlowska(597)94,45690,2113,648
(597)94,45690,2113,648
7.Related party transactions
During the year, the company made available a loan to the director. The balance of this loan as at 31 March 2025 was £3,648 (2024: -£597). The director has confirmed that £3,735 was repaid into the company bank account on 24 November 2025, which is within 9 months of the company year end and as such no additional S455 tax is due on the overdrawn loan balance at 31 March 2025. Interest has been charged on the balance on a monthly basis, at the UK market rate.